Back to Browse Journals » Clinical Ophthalmology » Volume 2 » Issue 2

Autoimmune destruction of pericytes as the cause of diabetic retinopathy

Authors Duncan D Adams

Published Date June 2008 Volume 2008:2(2) Pages 295—298

DOI http://dx.doi.org/10.2147/OPTH.S2629

Published 30 June 2008

Duncan D Adams

Faculty of Medicine, University of Otago, Dunedin, New Zealand

Abstract: In diabetic retinopathy, collapse of the retinal vasculature is associated with loss of the pericytes. These are contractile cells that together with endothelial cells form the terminal arterioles of the retina. The cause of the loss of pericytes is not known. Recently, it has been discovered that type 1 diabetes is caused by forbidden clones of cytotoxic T lymphocytes, which destroy the insulin-making cells with exquisite specificity. In the light of this, I postulate that an antigenically-related forbidden clone of cytotoxic T lymphocytes selectively destroys the pericytes and that this is the cause of the vascular collapse of diabetic retinopathy. If this is so, the therapeutic implications are immense, involving a switch from ineffectual tight glycemic control to immunotherapy. This is already used as immunosuppression to prevent organ transplant rejection, and as the immune ablation and autologous bone marrow cell reconstitution that has saved the lives of patients with lethally-severe scleroderma. Once the pericyte surface auto-antigen for the T lymphocytes has been isolated, selective destruction of the pathogenic T lymphocytes would be possible by manufacture and use of cytotoxic auto-antigen complexes, which arrests progression of the retinopathy.

Keywords: pericytes, diabetic retinopathy, autoimmunity, T cell forbidden clones, immunotherapy

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Assessment of β-zone peripapillary atrophy by optical coherence tomography and scanning laser ophthalmoscopy imaging in glaucoma patients

Seidensticker F, Reznicek L, Mann T, Huebert I, Kampik A, Ulbig M, Hirneiss C, Neubauer AS, Kernt M

Clinical Ophthalmology 2014, 8:1233-1239

Published Date: 27 June 2014

Complication rate of posterior capsule rupture with vitreous loss during phacoemulsification at a Hawaiian cataract surgical center: a clinical audit

Chen M, LaMattina KC, Patrianakos T, Dwarakanathan S

Clinical Ophthalmology 2014, 8:375-378

Published Date: 5 February 2014

Netilmicin/dexamethasone fixed combination in the treatment of conjunctival inflammation

Faraldi F, Papa V, Rasà D, Santoro D, Russo S

Clinical Ophthalmology 2013, 7:1239-1244

Published Date: 24 June 2013

Prevalence of drug resistance and culture-positive rate among microorganisms isolated from patients with ocular infections over a 4-year period

Shimizu Y, Toshida H, Honda R, Matsui A, Ohta T, Asada Y, Murakami A

Clinical Ophthalmology 2013, 7:695-702

Published Date: 9 April 2013

Fluorescein angiography findings in a case of Rubinstein-Taybi syndrome

Jacobs DJ, Sein J, Berrocal AM, Grajewski AL, Hodapp E

Clinical Ophthalmology 2012, 6:1369-1371

Published Date: 22 August 2012

Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome

Putignano S, Gareri P, Castagna A, Cerqua G, Cervera P, Cotroneo AM, Fiorillo F, Grella R, Lacava R, Maddonni A, Marino S, Pluderi A, Putignano D, Rocca F

Clinical Interventions in Aging 2012, 7:113-118

Published Date: 10 May 2012

Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects

Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G

Vascular Health and Risk Management 2011, 7:475-482

Published Date: 19 July 2011

New and emerging therapies for the treatment of rheumatoid arthritis

Michael G Feely

Open Access Rheumatology: Research and Reviews 2010, 2:35-43

Published Date: 28 July 2010